The HOPE trial: Ramipril significantly reduces cardiovascular events in high-risk patients with normal ejection fractions [Classics Series]
Image: CC/L. academia 1. Ramipril significantly reduces cardiovascular events including MI, stroke and death in high risk-patients in the absence ...